New Test May Be Better at Predicting Heart Attacks and Strokes

1. 1

   Researchers from Northwestern Medicine found that a new test called apolipoprotein B (apoB) is better than current tests for predicting who needs more aggressive treatment to reduce the risk of heart attacks and strokes. The study, published in JAMA, used a computer simulation to compare three approaches for guiding treatment: using apoB, LDL cholesterol, or non-HDL cholesterol levels.

2. 2

   Researchers from Northwestern Medicine found that a new test called apolipoprotein B (apoB) is better than current tests for predicting who needs more aggressive treatment to reduce the risk of heart attacks and strokes. The study, published in JAMA, used a computer simulation to compare three approaches for guiding treatment: using apoB, LDL cholesterol, or non-HDL cholesterol levels.

3. 3

   Researchers from Northwestern Medicine found that a new test called apolipoprotein B (apoB) is better than current tests for predicting who needs more aggressive treatment to reduce the risk of heart attacks and strokes. The study, published in JAMA, used a computer simulation to compare three approaches for guiding treatment: using apoB, LDL cholesterol, or non-HDL cholesterol levels.

4. 4

   Researchers from Northwestern Medicine found that a new test called apolipoprotein B (apoB) is better than current tests for predicting who needs more aggressive treatment to reduce the risk of heart attacks and strokes. The study, published in JAMA, used a computer simulation to compare three approaches for guiding treatment: using apoB, LDL cholesterol, or non-HDL cholesterol levels.